Clive Kelly

4.3k total citations · 1 hit paper
112 papers, 2.8k citations indexed

About

Clive Kelly is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Clive Kelly has authored 112 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 28 papers in Rheumatology and 27 papers in Physiology. Recurrent topics in Clive Kelly's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers), Rheumatoid Arthritis Research and Therapies (20 papers) and Systemic Sclerosis and Related Diseases (15 papers). Clive Kelly is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers), Rheumatoid Arthritis Research and Therapies (20 papers) and Systemic Sclerosis and Related Diseases (15 papers). Clive Kelly collaborates with scholars based in United Kingdom, United States and Tanzania. Clive Kelly's co-authors include J. Hamilton, V. Saravanan, C. Heycock, I D Griffiths, Julie Dawson, Felix Woodhead, Gouri Koduri, Muthu Periasamy, Philip Babij and Jennifer D. Hamilton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Clive Kelly

110 papers receiving 2.6k citations

Hit Papers

Rheumatoid arthritis-related interstitial lung disease: a... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clive Kelly United Kingdom 29 1.3k 915 774 557 452 112 2.8k
Elizabeth V. Arkema Sweden 30 998 0.8× 1.2k 1.3× 1.3k 1.7× 534 1.0× 391 0.9× 103 3.2k
A. H. Zwinderman Netherlands 26 832 0.6× 1.1k 1.2× 1.8k 2.3× 307 0.6× 330 0.7× 48 4.0k
Debashish Danda India 29 1.2k 0.9× 340 0.4× 1.1k 1.4× 250 0.4× 270 0.6× 180 3.1k
Amy L. Olson United States 28 3.5k 2.7× 1.8k 1.9× 640 0.8× 818 1.5× 852 1.9× 72 4.0k
Christian Pagnoux Canada 33 2.7k 2.1× 808 0.9× 1.5k 2.0× 275 0.5× 265 0.6× 192 3.5k
Olivier Fain France 30 483 0.4× 429 0.5× 689 0.9× 247 0.4× 422 0.9× 124 2.7k
Torkell Ellingsen Denmark 30 545 0.4× 361 0.4× 1.7k 2.2× 374 0.7× 355 0.8× 142 3.8k
Coralie Barbe France 28 671 0.5× 249 0.3× 311 0.4× 494 0.9× 466 1.0× 145 2.4k
Peter Lanyon United Kingdom 29 1.2k 0.9× 428 0.5× 1.8k 2.4× 183 0.3× 428 0.9× 87 3.4k
Doron Comaneshter Israel 31 408 0.3× 272 0.3× 932 1.2× 436 0.8× 429 0.9× 143 2.9k

Countries citing papers authored by Clive Kelly

Since Specialization
Citations

This map shows the geographic impact of Clive Kelly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive Kelly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive Kelly more than expected).

Fields of papers citing papers by Clive Kelly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clive Kelly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive Kelly. The network helps show where Clive Kelly may publish in the future.

Co-authorship network of co-authors of Clive Kelly

This figure shows the co-authorship network connecting the top 25 collaborators of Clive Kelly. A scholar is included among the top collaborators of Clive Kelly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clive Kelly. Clive Kelly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Downs, James & Clive Kelly. (2025). Improving Understanding, Recognition and Treatment for Men With Anorexia Nervosa. British Journal of Hospital Medicine. 86(6). 1–15. 1 indexed citations
2.
Kelly, Clive, et al.. (2024). Radiological Assessment of Fusobacterium Necrophorum Osteomyelitis and Septic Arthritis: A Case Report. Cureus. 16(10). e72264–e72264. 1 indexed citations
3.
Kelly, Clive, et al.. (2024). Recognising and responding to physical and mental health issues in neurodivergent girls and women. British Journal of Hospital Medicine. 85(4). 1–12. 9 indexed citations
4.
Halliday, Jo E. B., Christopher Bunn, Clive Kelly, et al.. (2024). Estimating the prevalence and predictors of musculoskeletal disorders in Tanzania: a cross-sectional pilot study. Pan African Medical Journal. 47. 36–36. 1 indexed citations
5.
Kelly, Clive, et al.. (2023). Recognising the Rheumatological Needs of Neurodivergent Females: Commentary. SHILAP Revista de lepidopterología. 3(4). 221–227. 3 indexed citations
6.
Raw, Rachael K., Jon Rees, Clive Kelly, Caroline Wroe, & David Chadwick. (2021). Prior COVID-19 infection is associated with increased Adverse Events (AEs) after the first, but not the second, dose of the BNT162b2/Pfizer vaccine. Vaccine. 40(3). 418–423. 12 indexed citations
7.
Yusof, Md Yuzaiful Md, M. I. Darby, Edward M Vital, et al.. (2020). THU0143 EFFECT OF RITUXIMAB OR TUMOUR NECROSIS FACTOR INHIBITORS ON LUNG INFECTION AND 5-YEAR SURVIVAL IN RHEUMATOID ARTHRITIS-ASSOCIATED BRONCHIECTASIS. Annals of the Rheumatic Diseases. 79. 286–287. 1 indexed citations
8.
Aringer, Martin, Janet Pope, Clive Kelly, et al.. (2020). THU0189 EFFICACY AND SAFETY OF NINTEDANIB IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED INTERSTITIAL LUNG DISEASE TREATED WITH DMARDS AND/OR GLUCOCORTICOIDS AT BASELINE. Annals of the Rheumatic Diseases. 79. 313–314. 3 indexed citations
9.
Kelly, Clive, et al.. (2016). Lung involvement in inflammatory rheumatic diseases. Best Practice & Research Clinical Rheumatology. 30(5). 870–888. 27 indexed citations
10.
Gordon, Judith R., David Middleton, Adam Young, et al.. (2015). 068. Cyclophosphamide in the Treatment of Severe Interstitial Lung Disease in Patients with Rheumatoid Arthritis. Lara D. Veeken. 1 indexed citations
11.
Narayanan, Kilimangalam, et al.. (2009). Common ground: The overlap between Endocrinology and Rheumatology. European Journal of Internal Medicine. 20(6). 569–571. 2 indexed citations
12.
Scott, Christopher, et al.. (2008). Evaluation of a dedicated short-stay unit for acute medical admissions. Clinical Medicine. 8(1). 18–20. 25 indexed citations
13.
Coyne, Peter, et al.. (2007). Acute lower respiratory tract infections in patients with rheumatoid arthritis.. PubMed. 34(9). 1832–6. 48 indexed citations
14.
Rajasekaran, Arvind, et al.. (2006). Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years.. PubMed. 33(7). 1250–3. 41 indexed citations
15.
Moschos, John, et al.. (2005). Idiopathic portal hypertension complicating systemic sclerosis: a case report. BMC Gastroenterology. 5(1). 16–16. 6 indexed citations
16.
Francis, Roger M., et al.. (2004). Acute and long-term management of patients with vertebral fractures. QJM. 97(2). 63–74. 40 indexed citations
17.
Heycock, C., et al.. (2002). What effect does Helicobacter pylori infection have on the risk of peptic ulceration in patients receiving NSAIDs for rheumatoid arthritis?. European Journal of Internal Medicine. 13(4). 269–273. 5 indexed citations
18.
Kelly, Clive, et al.. (2000). Ten year follow up of pulmonary function in patients with primary Sjögren’s syndrome. Annals of the Rheumatic Diseases. 59(9). 709–712. 87 indexed citations
19.
Kelly, Clive. (1993). Rheumatoid arthritis: classical rheumatoid lung disease. Baillière s Clinical Rheumatology. 7(1). 1–16. 25 indexed citations
20.
Stenton, SC, Clive Kelly, E. Haydn Walters, & D.J. Hendrick. (1988). Induction of bronchial hyperresponsiveness following smoke inhalation injury. British Journal of Diseases of the Chest. 82(4). 436–438. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026